Oil & Gas Exploration & Production
Build Your Comparison
Side-by-side financial analysisStock Comparison
VET vs BTE vs KO vs CVE vs MEG
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Exploration & Production
Beverages - Non-Alcoholic
Oil & Gas Integrated
Waste Management
VET vs BTE vs KO vs CVE vs MEG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production | Beverages - Non-Alcoholic | Oil & Gas Integrated | Waste Management |
| Market Cap | $1.71B | $3.43B | $355.61B | $53.24B | $566M |
| Revenue (TTM) | $1.81B | $529M | $49.28B | $49.40B | $821M |
| Net Income (TTM) | $-814M | $-740M | $13.70B | $4.64B | $6M |
| Gross Margin | 35.9% | -15.4% | 61.7% | 19.6% | 39.0% |
| Operating Margin | 20.2% | 16.1% | 29.3% | 14.0% | 2.0% |
| Forward P/E | 11.2x | 13.1x | 25.3x | 6.2x | 122.1x |
| Total Debt | $1.30B | $118M | $45.49B | $17.00B | $359M |
| Cash & Equiv. | $19M | $952M | $10.27B | $2.74B | $11M |
VET vs BTE vs KO vs CVE vs MEG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 20 | Jun 26 | Return |
|---|---|---|---|
| Vermilion Energy In… (VET) | 100 | 272.0 | +172.0% |
| Baytex Energy Corp. (BTE) | 100 | 987.2 | +887.2% |
| The Coca-Cola Compa… (KO) | 100 | 174.9 | +74.9% |
| Cenovus Energy Inc. (CVE) | 100 | 633.9 | +533.9% |
| Montrose Environmen… (MEG) | 100 | 96.8 | -3.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VET vs BTE vs KO vs CVE vs MEG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VET ranks third and is worth considering specifically for dividends.
- 4.1% yield, 3-year raise streak, vs KO's 2.5%
BTE has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and defensive.
- Lower volatility, beta 0.05, Low D/E 4.9%, current ratio 3.61x
- Beta 0.05, yield 1.4%, current ratio 3.61x
- Beta 0.05 vs MEG's 1.66, lower leverage
- +134.1% vs MEG's -33.3%
KO is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 27.8% margin vs BTE's -139.9%
- 13.1% ROA vs VET's -13.8%, ROIC 15.8% vs 3.5%
CVE is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.08, yield 2.0%
- 109.7% 10Y total return vs KO's 121.1%
- Lower P/E (6.2x vs 25.3x)
MEG is the clearest fit if your priority is growth exposure.
- Rev growth 19.3%, EPS growth 93.7%, 3Y rev CAGR 15.1%
- 19.3% revenue growth vs VET's -15.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.3% revenue growth vs VET's -15.0% | |
| Value | Lower P/E (6.2x vs 25.3x) | |
| Quality / Margins | 27.8% margin vs BTE's -139.9% | |
| Stability / Safety | Beta 0.05 vs MEG's 1.66, lower leverage | |
| Dividends | 4.1% yield, 3-year raise streak, vs KO's 2.5% | |
| Momentum (1Y) | +134.1% vs MEG's -33.3% | |
| Efficiency (ROA) | 13.1% ROA vs VET's -13.8%, ROIC 15.8% vs 3.5% |
VET vs BTE vs KO vs CVE vs MEG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
VET vs BTE vs KO vs CVE vs MEG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 3 of 6 categories
MEG leads 1 • CVE leads 1 • VET leads 0 • BTE leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CVE is the larger business by revenue, generating $49.4B annually — 93.4x BTE's $529M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to BTE's -139.9%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $529M | $49.3B | $49.4B | $821M |
| EBITDAEarnings before interest/tax | $1.2B | $412M | $15.5B | $12.4B | $67M |
| Net IncomeAfter-tax profit | -$814M | -$740M | $13.7B | $4.6B | $6M |
| Free Cash FlowCash after capex | $301M | $192M | $12.6B | $4.4B | $72M |
| Gross MarginGross profit ÷ Revenue | +35.9% | -15.4% | +61.7% | +19.6% | +39.0% |
| Operating MarginEBIT ÷ Revenue | +20.2% | +16.1% | +29.3% | +14.0% | +2.0% |
| Net MarginNet income ÷ Revenue | -44.9% | -139.9% | +27.8% | +9.4% | +0.7% |
| FCF MarginFCF ÷ Revenue | +16.6% | +36.4% | +25.5% | +8.8% | +8.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.4% | -48.8% | +12.1% | -12.8% | -5.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -10.9% | -2.0% | +18.2% | +78.7% | +45.3% |
Valuation Metrics
MEG leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 18.4x trailing earnings, CVE trades at a 32% valuation discount to KO's 27.2x P/E. On an enterprise value basis, VET's 3.9x EV/EBITDA is more attractive than KO's 26.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.7B | $3.4B | $355.6B | $53.2B | $566M |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $2.8B | $390.8B | $63.4B | $913M |
| Trailing P/EPrice ÷ TTM EPS | -3.68x | -8.32x | 27.18x | 18.38x | -111.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.20x | 13.08x | 25.27x | 6.18x | 122.09x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.43x | — | — |
| EV / EBITDAEnterprise value multiple | 3.92x | 5.44x | 26.39x | 9.04x | 14.38x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 3.25x | 7.42x | 1.50x | 0.68x |
| Price / BookPrice ÷ Book value/share | 1.08x | 2.09x | 10.40x | 2.28x | 1.22x |
| Price / FCFMarket cap ÷ FCF | 7.32x | 19.49x | 67.15x | 21.86x | 6.21x |
Profitability & Efficiency
KO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-34 for VET. BTE carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to KO's 1.33x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs VET's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -33.7% | -23.1% | +41.1% | +15.2% | +1.3% |
| ROA (TTM)Return on assets | -13.8% | -13.6% | +13.1% | +7.8% | +0.6% |
| ROICReturn on invested capital | +3.5% | +4.2% | +15.8% | +7.9% | +1.3% |
| ROCEReturn on capital employed | +3.3% | +4.4% | +17.3% | +8.2% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 7 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.59x | 0.05x | 1.33x | 0.54x | 0.80x |
| Net DebtTotal debt minus cash | $1.3B | -$834M | $35.2B | $14.3B | $348M |
| Cash & Equiv.Liquid assets | $19M | $952M | $10.3B | $2.7B | $11M |
| Total DebtShort + long-term debt | $1.3B | $118M | $45.5B | $17.0B | $359M |
| Interest CoverageEBIT ÷ Interest expense | 2.53x | 0.33x | 10.70x | 11.80x | 4.67x |
Total Returns (Dividends Reinvested)
CVE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVE five years ago would be worth $30,275 today (with dividends reinvested), compared to $3,136 for MEG. Over the past 12 months, BTE leads with a +134.1% total return vs MEG's -33.3%. The 3-year compound annual growth rate (CAGR) favors CVE at 21.4% vs MEG's -28.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +31.7% | +41.1% | +20.3% | +62.1% | -37.1% |
| 1-Year ReturnPast 12 months | +45.6% | +134.1% | +17.2% | +100.1% | -33.3% |
| 3-Year ReturnCumulative with dividends | +4.0% | +45.6% | +47.0% | +79.1% | -63.0% |
| 5-Year ReturnCumulative with dividends | +41.4% | +164.8% | +65.6% | +202.8% | -68.6% |
| 10-Year ReturnCumulative with dividends | -39.7% | -18.6% | +121.1% | +109.7% | -30.1% |
| CAGR (3Y)Annualised 3-year return | +1.3% | +13.3% | +13.7% | +21.4% | -28.2% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than MEG's 1.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs MEG's 48.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.18x | 0.05x | -0.20x | 0.08x | 1.66x |
| 52-Week HighHighest price in past year | $14.82 | $5.36 | $84.04 | $32.07 | $32.00 |
| 52-Week LowLowest price in past year | $7.00 | $1.76 | $65.35 | $13.47 | $14.13 |
| % of 52W HighCurrent price vs 52-week peak | +75.2% | +86.6% | +98.3% | +88.2% | +48.9% |
| RSI (14)Momentum oscillator 0–100 | 40.9 | 43.6 | 60.6 | 48.8 | 25.8 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 19.0M | 12.7M | 7.9M | 444K |
Analyst Outlook
Evenly matched — VET and KO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VET as "Hold", BTE as "Buy", KO as "Buy", CVE as "Hold", MEG as "Buy". Consensus price targets imply 215.4% upside for MEG (target: $49) vs -3.7% for VET (target: $11). For income investors, VET offers the higher dividend yield at 4.10% vs MEG's 0.76%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $10.74 | — | $86.13 | $29.00 | $49.33 |
| # AnalystsCovering analysts | 10 | 16 | 48 | 27 | 12 |
| Dividend YieldAnnual dividend ÷ price | +4.1% | +1.4% | +2.5% | +2.0% | +0.8% |
| Dividend StreakConsecutive years of raises | 3 | 0 | 56 | 5 | 0 |
| Dividend / ShareAnnual DPS | $0.64 | $0.09 | $2.04 | $0.78 | $0.12 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +0.6% | +0.2% | +3.4% | +21.6% |
KO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MEG leads in 1 (Valuation Metrics). 1 tied.
VET vs BTE vs KO vs CVE vs MEG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VET or BTE or KO or CVE or MEG a better buy right now?
For growth investors, Montrose Environmental Group, Inc.
(MEG) is the stronger pick with 19. 3% revenue growth year-over-year, versus -15. 0% for Vermilion Energy Inc. (VET). Cenovus Energy Inc. (CVE) offers the better valuation at 18. 4x trailing P/E (6. 2x forward), making it the more compelling value choice. Analysts rate Baytex Energy Corp. (BTE) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VET or BTE or KO or CVE or MEG?
On trailing P/E, Cenovus Energy Inc.
(CVE) is the cheapest at 18. 4x versus The Coca-Cola Company at 27. 2x. On forward P/E, Cenovus Energy Inc. is actually cheaper at 6. 2x.
03Which is the better long-term investment — VET or BTE or KO or CVE or MEG?
Over the past 5 years, Cenovus Energy Inc.
(CVE) delivered a total return of +202. 8%, compared to -68. 6% for Montrose Environmental Group, Inc. (MEG). Over 10 years, the gap is even starker: KO returned +121. 1% versus VET's -39. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VET or BTE or KO or CVE or MEG?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus Montrose Environmental Group, Inc. 's 1. 66β — meaning MEG is approximately -927% more volatile than KO relative to the S&P 500. On balance sheet safety, Baytex Energy Corp. (BTE) carries a lower debt/equity ratio of 5% versus 133% for The Coca-Cola Company — giving it more financial flexibility in a downturn.
05Which is growing faster — VET or BTE or KO or CVE or MEG?
By revenue growth (latest reported year), Montrose Environmental Group, Inc.
(MEG) is pulling ahead at 19. 3% versus -15. 0% for Vermilion Energy Inc. (VET). On earnings-per-share growth, the picture is similar: Montrose Environmental Group, Inc. grew EPS 93. 7% year-over-year, compared to -1313. 3% for Vermilion Energy Inc.. Over a 3-year CAGR, MEG leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VET or BTE or KO or CVE or MEG?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus -40. 8% for Baytex Energy Corp. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 1. 5% for MEG. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VET or BTE or KO or CVE or MEG more undervalued right now?
On forward earnings alone, Cenovus Energy Inc.
(CVE) trades at 6. 2x forward P/E versus 122. 1x for Montrose Environmental Group, Inc. — 115. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MEG: 215. 4% to $49. 33.
08Which pays a better dividend — VET or BTE or KO or CVE or MEG?
All stocks in this comparison pay dividends.
Vermilion Energy Inc. (VET) offers the highest yield at 4. 1%, versus 0. 8% for Montrose Environmental Group, Inc. (MEG).
09Is VET or BTE or KO or CVE or MEG better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 5% yield, +121. 1% 10Y return). Montrose Environmental Group, Inc. (MEG) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +121. 1%, MEG: -30. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VET and BTE and KO and CVE and MEG?
These companies operate in different sectors (VET (Energy) and BTE (Energy) and KO (Consumer Defensive) and CVE (Energy) and MEG (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VET is a small-cap income-oriented stock; BTE is a small-cap quality compounder stock; KO is a large-cap quality compounder stock; CVE is a mid-cap quality compounder stock; MEG is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.